Ashley Pariser

443 total citations
23 papers, 268 citations indexed

About

Ashley Pariser is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ashley Pariser has authored 23 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ashley Pariser's work include Breast Cancer Treatment Studies (10 papers), Advanced Breast Cancer Therapies (5 papers) and Cancer survivorship and care (5 papers). Ashley Pariser is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Advanced Breast Cancer Therapies (5 papers) and Cancer survivorship and care (5 papers). Ashley Pariser collaborates with scholars based in United States. Ashley Pariser's co-authors include Rodney L. Levine, Emily Shacter, Timothy D. Veenstra, Baolin Zhang, Li‐Rong Yu, Fábio Klamt, Yaqin Zhang, Stéphanie Zdanov, Sarah S. Mougalian and Margaret E. Gatti‐Mays and has published in prestigious journals such as Journal of Clinical Oncology, Nature Cell Biology and Cancer Research.

In The Last Decade

Ashley Pariser

18 papers receiving 264 citations

Peers

Ashley Pariser

PHYSI

ONCOL

Hannah Sunshine United States

Editha Bayer Austria

Armella Zadoorian Australia

Yue Fei China

John J. Shacka United States

Kamil Sołtysik Japan

Chia-Feng Tsai Taiwan

Shefali Krishna United States

Kirti Jain United States

Jon Roffey United Kingdom

Hannah Sunshine United States

Ashley Pariser

232 ×1.8

43 ×0.6

48 ×0.9

38 ×0.9

PHYSI

21 ×0.5

ONCOL

Citations per year, relative to Ashley Pariser Ashley Pariser (= 1×) peers Hannah Sunshine

Countries citing papers authored by Ashley Pariser

Since Specialization

Citations

This map shows the geographic impact of Ashley Pariser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Pariser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Pariser more than expected).

Fields of papers citing papers by Ashley Pariser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Pariser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Pariser. The network helps show where Ashley Pariser may publish in the future.

Co-authorship network of co-authors of Ashley Pariser

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley Pariser. A scholar is included among the top collaborators of Ashley Pariser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley Pariser. Ashley Pariser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Azam, Shadi, Saurabh Deepak Chitnis, Katharine A. Collier, et al.. (2024). Association between Inflammatory Dietary Pattern and Mammographic Features. Journal of Nutrition. 154(11). 3437–3445. 1 indexed citations

Sukumar, Jasmine, Sagar Sardesai, Ai Ni, et al.. (2024). Real‐world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer. Cancer Medicine. 13(12). e7317–e7317.

Quiroga, Dionisia, Ashley Pariser, Michael Grimm, et al.. (2024). Axillary Management: How Much Is Too Much?. Current Oncology Reports. 26(7). 735–743. 3 indexed citations

Williams, Nicole, Marilly Palettas, Julie Stephens, et al.. (2024). Abstract PO5-17-04: Tolerability of pertuzumab in older adults with HER2 positive breast cancer: A single institution experience. Cancer Research. 84(9_Supplement). PO5–17.

Ni, Ai, Dionisia Quiroga, Ashley Pariser, et al.. (2024). The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer. npj Breast Cancer. 10(1). 49–49. 3 indexed citations

Goldstein, Daniel A., Dionisia Quiroga, Mahmoud Kassem, et al.. (2023). The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer. Oncology and Therapy. 11(3). 361–374. 1 indexed citations

Sukumar, Jasmine, Sagar Sardesai, Ai Ni, et al.. (2023). Abstract P1-02-03: Real World Treatment Patterns of Adjuvant Endocrine Therapy and Ovarian Suppression in Premenopausal HR+/HER2+ Breast Cancer. Cancer Research. 83(5_Supplement). P1–2. 1 indexed citations

Quiroga, Dionisia, Michael Grimm, Julie Stephens, et al.. (2023). Abstract P4-02-17: Impact of low hormone receptor expression on neoadjuvant chemotherapy response and patterns of care in early-stage HER2-negative breast cancer: a US National Cancer Database analysis. Cancer Research. 83(5_Supplement). P4–2.

Gaughan, Alice A., Sarah R. MacEwan, Laura J. Rush, et al.. (2023). Perspectives of patients undergoing neoadjuvant chemotherapy for breast cancer during the COVID‐19 pandemic. Cancer Reports. 6(10). e1882–e1882. 2 indexed citations

10.

Grimm, Michael, Jasmine Sukumar, Patrick Schnell, et al.. (2023). Survival outcomes seen with neoadjuvant chemotherapy in the management of locally advanced inflammatory breast cancer (IBC) versus matched controls. The Breast. 72. 103591–103591. 4 indexed citations

11.

Wang, Ton, Ashley Pariser, Mathew Cherian, et al.. (2023). Radiation Management for Breast Cancer After Neoadjuvant Therapy. Current Breast Cancer Reports. 15(4). 371–378. 1 indexed citations

12.

Pariser, Ashley, et al.. (2022). Delivery of Cancer Survivorship Education to Community Healthcare Professionals. Journal of Cancer Education. 38(2). 625–631. 2 indexed citations

13.

Palettas, Marilly, Michael Grimm, Mahmoud Kassem, et al.. (2022). Abstract P4-09-08: Examining neurocognitive function in breast-cancer patients after chemotherapy. Cancer Research. 82(4_Supplement). P4–9.

14.

Collier, Katharine A., Zachary Weber, Elizabeth Adams, et al.. (2022). Abstract P3-09-09: Serial circulating tumor DNA from patients with metastatic breast cancer with and without BRCA1/2 mutations. Cancer Research. 82(4_Supplement). P3–9.

15.

Ni, Ai, Michael Grimm, Sagar Sardesai, et al.. (2022). The survival benefit of anti-HER2 treatment in the management of small (T1mic, T1a, T1b, T1c), node-negative HER2+ breast cancer.. Journal of Clinical Oncology. 40(16_suppl). 532–532. 1 indexed citations

16.

Grimm, Michael, Nicole Williams, Mathew Cherian, et al.. (2022). Living with Advanced Breast Cancer: A Descriptive Analysis of Survivorship Strategies. Journal of Clinical Medicine. 11(14). 3992–3992. 10 indexed citations

17.

Sukumar, Jasmine, Dionisia Quiroga, Mahmoud Kassem, et al.. (2021). Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancer. Breast Cancer Research and Treatment. 190(2). 183–188. 14 indexed citations

18.

Williams, Nicole, Richard G. Paxman, Mahmoud Kassem, et al.. (2021). Real-world data on usage of scalp cooling for chemotherapy associated alopecia in the United States.. Journal of Clinical Oncology. 39(15_suppl). e18739–e18739. 1 indexed citations

19.

Pariser, Ashley, et al.. (2019). Utilization, duration, and outcomes of neoadjuvant endocrine therapy in the United States. Breast Cancer Research and Treatment. 178(2). 419–426. 16 indexed citations

20.

Klamt, Fábio, Stéphanie Zdanov, Rodney L. Levine, et al.. (2009). Oxidant-induced apoptosis is mediated by oxidation of the actin-regulatory protein cofilin. Nature Cell Biology. 11(10). 1241–1246. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact